ABCC5 and breast carcinoma: The findings indicate that ABCC5 was most highly expressed in breast cancer cells exhibiting a bone metastasis phenotype in the absence of therapy (anti-oestrogen, chemotherapy, or bisphosphonates) (Mourskaia et al., 2012).